CIMTEC announces appointment of Justin Leushner as CEO

Brings deep experience in medtech commercialization

LONDON (August 8, 2017) – The Centre for Imaging Technology Commercialization (CIMTEC) is pleased to announce the appointment of Mr. Justin Leushner as Chief Executive Officer, effective today. Mr. Leushner will provide strategic direction to CIMTEC in achieving its vision of being recognized as the global expert in accelerating medical imaging and imaging-related commercialization.

Mr. Leushner brings to CIMTEC extensive experience as an entrepreneur with start-up companies in medical devices, diagnostics, and therapeutics. He was responsible for developing a national molecular diagnostics program for MDS Inc., Canada's largest life sciences company, and served as a business analyst and portfolio advisor to the Canadian Medical Discoveries Fund. In 2004, Mr. Leushner co-founded Sernova Corp., which is now traded on the Toronto Stock Exchange. He developed an Islet Transplant Program for the London Health Sciences Centre and served as a Director for Health Care Restructuring. Most recently Mr. Leushner was Vice President at TechAlliance of South Western Ontario, where he managed a team of advisors, analysts and Entrepreneurs-in-Residence, working with more than 300 companies. An MBA graduate of Western University’s Ivey School of Business, Mr. Leushner also holds a B.Sc. in Cell Physiology/Genetics from the University of British Columbia and numerous technical designations in Forensic Science and Molecular Biology.

“I’m very excited to join CIMTEC and work with companies across the imaging-related medical technology sector to expand the impact of science on Canada’s economy and Canadians’ health,” said Mr. Leushner. “I will be using all my experience in stimulating commercialization in Ontario, but now on a national stage, working with innovators from coast to coast.”

“CIMTEC is a key player in fostering and supporting new and existing companies as they transform Canadian-made innovation into economic success,” said CIMTEC founder and Chief Scientific Officer Dr. Aaron Fenster. “Justin’s leadership strengths and his knowledge of the challenges of commercializing Canadian research discoveries here in Canada will enrich CIMTEC’s well-earned reputation as a global leader in its field.”

“We are thrilled that Justin is leading CIMTEC,” added Board of Directors Chair Dr. Michael Wood. “And what an exciting time as CIMTEC reaches across Canada through the National Network of MedTech Clusters, investing in emerging companies through the MedTech Investment Fund.”

CIMTEC works with researchers and SMEs in the imaging-related medical technology sectors to accelerate the commercialization of imaging innovations, leading to improved understanding, diagnosis and treatment of human disease and improving the quality of healthcare in Canada and globally. CIMTEC provides spin-off companies and SMEs with a unique combination of business expertise, technical capabilities and links to clinicians and infrastructure to allow them to become internationally competitive. CIMTEC is funded by the networks of Centres of Excellence (NCE) through its Centres of Excellence for Commercialization and Research (CECR) program. It is headquartered in Toronto and London, Ontario.

-30-

For further information

Carol Richardson

Executive Director of Operations

519-639-1235

carol.richardson@cimtec-canada.ca

www.cimtec-canada.ca